Ferment.Co

What Ferment.Co does

Ferment.Co is a venture creation studio founded in 2021 by Jason Kakoyiannis in Chapel Hill, North Carolina, that concepts, incubates, and launches new companies applying programmed biology to industrial and consumer problems across energy, materials, agriculture, and health. The studio's central technical approach is to build portfolio companies 'born platform native' on Ginkgo Bioworks' synthetic biology foundry, granting ventures access to automated high-throughput build/test cycles, pre-packed cell development kits, and pre-debugged biological code assets that materially shorten the path from problem definition to first revenue (targeted at under 2.5 years per venture). Ferment has codified company-building playbooks, stage-gate processes, and SOPs to standardize venture creation across sectors.

Ferment operates a hybrid go-to-market combining an Entrepreneur-in-Residence (EIR) program — $50,000 for the initial design phase and up to $3 million in subsequent seed funding for selected EIRs — with direct outreach to corporate strategics that co-build, co-invest, and provide offtake validation. Named partners include Elanco, Suncor, Chanel, BHP, Givaudan, Olaplex, Vale, Nutreco, and Battelle Memorial Institute, supported by financial backers Viking Global, Cascade, LIOF, and Fibrant BV. Revenue is generated through equity ownership in portfolio companies and strategic corporate partnership arrangements; pricing is structured around staged funding tranches rather than a product license or subscription.

Since inception Ferment has created seven portfolio companies: Arcaea (active beauty and personal care, with Chanel and Givaudan), Verb Biotics (consumer probiotics), Ayana Bio (plant bioactives for nutrition), Allonnia (industrial waste remediation including PFAS, with Battelle, Suncor, and BHP), BiomEdit (probiotics and microbial medicines for animal health, with Elanco), Alchemyca (biogas efficiency via digital twins and biological catalysts, launched 2024), and Pegasus Materials (bio-based high-performance polymers for electronics, data centers, and aerospace 3D printing, launched November 2024). The studio announced a $20 million dedicated fund in November 2024 to continue launching bio-empowered companies across additional sectors.

Name

Ferment.Co

Legal name

Ferment.Co

Website

https://ferment.co

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Ferment.Co is a venture creation studio founded in 2021 that concepts, incubates, and launches synthetic biology companies across beauty, nutrition, waste remediation, animal health, renewable energy, and advanced materials, partnering with corporate strategics and EIRs to build ventures natively on the Ginkgo Bioworks foundry platform.

Ownership category

akta.pro rank

Product category

Biotech Venture Studio Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids) (EUAAAIAL)

akta.pro secondary industries

Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM), Biofuels & Renewable Fuels Switching (Biomethane/RNG, Bio-oils, Sustainable Biomass) (EUABAJAD), Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol) (EUAAAIAA), Biofuel Plant EPC, O&M & Process Technology Providers (EUAAAHAK), Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation) (AFAKAGAH)

Keywords

• Venture studio creation
• Synthetic biology platforms
• Biotech company incubation
• Bio-empowered ventures
• Programmed biology startups

Headquarters

HQ city

Chapel Hill

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Equity Stakes in Portfolio Companies: Ferment generates returns through equity ownership in companies they create and incubate. As a venture studio, they take ownership stakes in new ventures in exchange for capital, resources, and company-building expertise.
2. Strategic Corporate Partnerships: Revenue generated through partnerships with corporate strategics who co-build ventures, provide investment capital, and commercialize products developed through Ferment's company creation process.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Ferment.Co is a venture creation studio that concepts, incubates, and launches new companies using programmed biology across energy, materials, agriculture, and health sectors. The studio provides $50,000 initial design-phase funding and up to $3M in seed funding to selected Entrepreneurs-in-Residence, deploys a $20M studio fund, and produces a portfolio of bio-enabled companies including Arcaea, Allonnia, BiomEdit, Ayana Bio, Verb Biotics, Alchemyca, and Pegasus Materials. Ferment companies are built platform-native on Ginkgo Bioworks' synthetic biology foundry infrastructure, combining biology with digital twins, AI/ML, and computational tools.

Product overview

Ferment.Co operates as a company creation studio that concepts, incubates, and launches new businesses using programmed biology. Rather than offering a single unified product, Ferment builds a portfolio of distinct companies across diverse sectors: Arcaea (beauty/personal care), Verb Biotics (probiotics/nutrition), Ayana Bio (plant bioactives), Allonnia (waste remediation), BiomEdit (animal health), Alchemyca (biogas efficiency), and Pegasus Materials (high-performance bio-based materials). Each portfolio company focuses on translating biotechnology into problem-solving products and applications in markets they know intimately, leveraging world-class biotech platforms like Ginkgo Bioworks.

Differentiator

Problem solved

Functional benefit

Products and services

• Ferment Venture Studio Venture creation studio service that concepts, incubates, and launches new bio-enabled product companies, providing EIR program ($50K design phase, up to $3M seed), company-building playbooks, corporate partner network, and access to synthetic biology foundry infrastructure. For visionary founders, industry operators, and corporate strategics.
• Arcaea Beauty and personal care company bringing biotech-based ingredients, new product formats, and unique stories to brands and consumers rooted in skin's relationship to biology. Includes the Future Society consumer fragrance brand with scents derived from extinct flowers. For beauty brands and consumers.
• Verb Biotics Consumer probiotics company designing a new wave of probiotics with meaningful nutritional benefits using Ginkgo's high throughput selection and genetic engineering tools. For consumer nutrition brands and end consumers.
• Ayana Bio
• Allonnia
• BiomEdit
• Alchemyca
• Pegasus Materials

Quantifiable outcome

• Portfolio companies reach initial revenue generation in under 2.5 years
• +3 more outcomes

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Wooree Green SciencecoreStrategic or Co-development Partner · 24 January 2024Seven-figure joint development agreement between Ayana Bio and Wooree Green Science to develop plant cell-derived saffron and other bioactive ingredients for health and wellness products for the South Korean market. Addresses agricultural supply chain constraints through sustainable plant cell cultivation.
• Ginkgo BioworkscoreTechnology or IntegrationGinkgo Bioworks serves as Ferment's primary biotechnology platform partner. Ferment companies are 'born platform native' on Ginkgo's foundries, accessing automated instrumentation, high-throughput build/test capabilities, biological code assets, and cell development kits. Jason Kakoyiannis was formerly Head of Ventures at Ginkgo before founding Ferment in 2021.
• ElancocoreStrategic or Co-development PartnerElanco partnered with Ferment to co-develop BiomEdit, creating probiotics and microbial medicines for animal health. Elanco is a founding partner providing industry expertise, and former EVP Aaron Schacht serves as BiomEdit CEO.
• Battelle Memorial InstitutecoreStrategic or Co-development PartnerBattelle is a strategic research partner that co-founded Allonnia, bringing deep knowledge of engineered remediation systems to the waste remediation company.
• SuncorcoreStrategic or Co-development PartnerCanadian oil and gas giant Suncor is a corporate partner with meaningful waste challenges, co-developing biological solutions for industrial waste remediation through Allonnia.
• GivaudancoreStrategic or Co-development PartnerGlobal flavor and fragrance company Givaudan is a sophisticated supplier partner for Arcaea, collaborating on biotech-based beauty and personal care ingredients. Givaudan perfumers also worked with Arcaea on Future Society fragrances.
• OlaplexminorStrategic or Co-development PartnerCategory disruptor in beauty, Olaplex is an innovative partner investor in Arcaea bringing novel hair care technology perspective.
• ValeminorStrategic or Co-development PartnerBrazilian mining corporation Vale is a strategic partner listed on Ferment's corporate partners page, likely for potential bio-based solutions in mining and materials.
• NutrecominorStrategic or Co-development PartnerAnimal nutrition company Nutreco partnered with BiomEdit to transform feed additives through microbiome technology, combining biology with animal health expertise.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Motif FoodWorks: Food-tech company developing novel ingredients via precision fermentation, originally spun out of Ginkgo Bioworks with leadership involvement from Ferment's founder. Directly comparable in business model (Ginkgo-born synbio ingredient company) and overlapping with Verb Biotics.
• Bota Bio: Industrial biotechnology company developing engineered microbes and bioprocesses for chemical and material production. Comparable to Ferment's Pegasus Materials and Ayana Bio in translating synthetic biology into bio-based chemicals, materials, and ingredients at scale.
• Petri: Biotech startup studio and accelerator funding early-stage synthetic biology and life science ventures. Comparable to Ferment in deploying small teams and capital to launch multiple bio-based product companies, though Petri operates more as an accelerator model.
• Flagship Pioneering: The original biotech venture creation studio, originating companies like Moderna and Generate Biomedicines. Highly comparable to Ferment as a founder-led model that repeatedly creates and incubates platform-based life science companies from ideation through venture funding.
• LanzaTech: Carbon-negative synbio company that Ferment's Alchemyca portfolio closely resembles in technology approach (gas fermentation/biocatalysts). Comparable as a venture-backed synbio company creator in industrial decarbonisation and renewable fuels.

Emerging players

• Invaio Sciences: Flagship Pioneering-incubated company applying biological engineering to agriculture and health. Comparable as a venture-studio-incubated synbio company targeting industrials and life sciences, with a similar platform-to-product translation model.
• Pangea Bio: AI-driven natural product discovery company building a portfolio of bioactives for health and wellness, overlapping directly with Ferment's Ayana Bio and Verb Biotics theses. Comparable as an emerging player in computational bioactives and synbio-enabled ingredient discovery.

Broad incumbents

• Ginkgo Bioworks: Public synthetic biology platform company and Ferment's primary foundry partner. Comparable as a broader incumbent in the same synbio ecosystem, but operates its own spinout engine (Motif, Joyn) which overlaps with Ferment's portfolio thesis rather than competing head-to-head.
• Resilience (National Resilience, Inc.): Biomanufacturing and synthetic biology company building infrastructure across pharma and industrial biotech. Comparable as a broader incumbent in the same synbio operating space, though focused more on biomanufacturing capacity than venture creation.

Others

• Culture Biosciences: Cloud bioprocess development and fermentation services provider for synbio companies. Comparable as enabling infrastructure for synthetic biology company creation, serving a customer base that overlaps with Ferment's portfolio and EIR pipeline.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fermentco

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ferment.Co